180 related articles for article (PubMed ID: 15385295)
1. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT.
Jin GY; Lee JM; Lee YC; Han YM; Lim YS
AJR Am J Roentgenol; 2004 Oct; 183(4):1013-20. PubMed ID: 15385295
[TBL] [Abstract][Full Text] [Related]
2. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors.
Bojarski JD; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2005 Aug; 185(2):466-71. PubMed ID: 16037522
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.
Lim HK; Choi D; Lee WJ; Kim SH; Lee SJ; Jang HJ; Lee JH; Lim JH; Choo IW
Radiology; 2001 Nov; 221(2):447-54. PubMed ID: 11687689
[TBL] [Abstract][Full Text] [Related]
4. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.
Suh RD; Wallace AB; Sheehan RE; Heinze SB; Goldin JG
Radiology; 2003 Dec; 229(3):821-9. PubMed ID: 14657317
[TBL] [Abstract][Full Text] [Related]
5. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer--a preliminary report of 33 patients.
Belfiore G; Moggio G; Tedeschi E; Greco M; Cioffi R; Cincotti F; Rossi R
AJR Am J Roentgenol; 2004 Oct; 183(4):1003-11. PubMed ID: 15385294
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device.
Laganà D; Carrafiello G; Mangini M; Boni L; Dionigi G; Fusi MC; Cinquepalmi L; Rovera F; Cuffari S; Fugazzola C
Surg Endosc; 2006 Aug; 20(8):1262-7. PubMed ID: 16858532
[TBL] [Abstract][Full Text] [Related]
8. CT volumetric assessment of pulmonary neoplasms after radiofrequency ablation: when to consider a second intervention?
Nour-Eldin NE; Naguib NN; Tawfik AM; Gruber-Rouh T; Zangos S; Vogl TJ
J Vasc Interv Radiol; 2014 Mar; 25(3):347-54. PubMed ID: 24581459
[TBL] [Abstract][Full Text] [Related]
9. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up.
Palussière J; Marcet B; Descat E; Deschamps F; Rao P; Ravaud A; Brouste V; de Baère T
Cardiovasc Intervent Radiol; 2011 Oct; 34(5):989-97. PubMed ID: 21127867
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.
VanSonnenberg E; Shankar S; Morrison PR; Nair RT; Silverman SG; Jaklitsch MT; Liu F; Cheung L; Tuncali K; Skarin AT; Sugarbaker DJ
AJR Am J Roentgenol; 2005 Feb; 184(2):381-90. PubMed ID: 15671350
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours.
Rossi S; Dore R; Cascina A; Vespro V; Garbagnati F; Rosa L; Ravetta V; Azzaretti A; Di Tolla P; Orlandoni G; Pozzi E
Eur Respir J; 2006 Mar; 27(3):556-63. PubMed ID: 16507856
[TBL] [Abstract][Full Text] [Related]
12. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience.
Yasui K; Kanazawa S; Sano Y; Fujiwara T; Kagawa S; Mimura H; Dendo S; Mukai T; Fujiwara H; Iguchi T; Hyodo T; Shimizu N; Tanaka N; Hiraki Y
Radiology; 2004 Jun; 231(3):850-7. PubMed ID: 15105453
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of pulmonary lesions.
Cariati M; Giordano G; Midulla M; Calati AM; Sacrini A; Raveglia F; Cornalba GP
Radiol Med; 2007 Mar; 112(2):149-56. PubMed ID: 17361380
[TBL] [Abstract][Full Text] [Related]
14. Imaging findings after radiofrequency ablation of adrenal tumors.
Brook OR; Mendiratta-Lala M; Brennan D; Siewert B; Faintuch S; Goldberg SN
AJR Am J Roentgenol; 2011 Feb; 196(2):382-8. PubMed ID: 21257891
[TBL] [Abstract][Full Text] [Related]
15. Multidetector-row computed tomography of focal liver lesions treated by radiofrequency ablation: spectrum of findings at long-term follow-up.
Filippone A; Iezzi R; Di Fabio F; Cianci R; Grassedonio E; Storto ML
J Comput Assist Tomogr; 2007; 31(1):42-52. PubMed ID: 17259832
[TBL] [Abstract][Full Text] [Related]
16. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
[TBL] [Abstract][Full Text] [Related]
17. Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors.
Sharma A; Digumarthy SR; Kalra MK; Lanuti M; Shepard JA
AJR Am J Roentgenol; 2010 May; 194(5):1250-6. PubMed ID: 20410411
[TBL] [Abstract][Full Text] [Related]
18. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors.
Javadi S; Ahrar JU; Ninan E; Gupta S; Matin SF; Ahrar K
J Vasc Interv Radiol; 2010 May; 21(5):690-5. PubMed ID: 20227295
[TBL] [Abstract][Full Text] [Related]
19. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
Linden PA; Wee JO; Jaklitsch MT; Colson YL
Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.
Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W
J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
